122 related articles for article (PubMed ID: 23747810)
1. 2-cinnamamido, 2-(3-phenylpropiolamido), and 2-(3-phenylpropanamido)benzamides: synthesis, antiproliferative activity, and mechanism of action.
Raffa D; Maggio B; Raimondi MV; Cusimano MG; Amico G; Carollo A; Conaldi PG; Bai R; Hamel E; Daidone G
Eur J Med Chem; 2013 Jul; 65():427-35. PubMed ID: 23747810
[TBL] [Abstract][Full Text] [Related]
2. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionality.
Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Cancemi G; D'Anneo A; Lauricella M; Cusimano MG; Bai R; Hamel E; Daidone G
Bioorg Med Chem; 2015 Oct; 23(19):6305-16. PubMed ID: 26344588
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
Demchuk DV; Samet AV; Chernysheva NB; Ushkarov VI; Stashina GA; Konyushkin LD; Raihstat MM; Firgang SI; Philchenkov AA; Zavelevich MP; Kuiava LM; Chekhun VF; Blokhin DY; Kiselyov AS; Semenova MN; Semenov VV
Bioorg Med Chem; 2014 Jan; 22(2):738-55. PubMed ID: 24387982
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors.
Li Y; Wang Y; Xie N; Xu M; Qian P; Zhao Y; Li S
Eur J Med Chem; 2015 Jul; 100():270-6. PubMed ID: 26140961
[TBL] [Abstract][Full Text] [Related]
6. Novel 4-(3-phenylpropionamido), 4-(2-phenoxyacetamido) and 4-(cinnamamido) substituted benzamides bearing the pyrazole or indazole nucleus: synthesis, biological evaluation and mechanism of action.
Raffa D; D'Anneo A; Plescia F; Daidone G; Lauricella M; Maggio B
Bioorg Chem; 2019 Mar; 83():367-379. PubMed ID: 30408649
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides.
Raffa D; Maggio B; Plescia F; Cascioferro S; Plescia S; Raimondi MV; Daidone G; Tolomeo M; Grimaudo S; Di Cristina A; Pipitone RM; Bai R; Hamel E
Eur J Med Chem; 2011 Jul; 46(7):2786-96. PubMed ID: 21530013
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
Wang XM; Xin MH; Xu J; Kang BR; Li Y; Lu SM; Zhang SQ
Eur J Med Chem; 2015; 96():382-95. PubMed ID: 25911625
[TBL] [Abstract][Full Text] [Related]
9. Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation.
Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
Eur J Med Chem; 2013 Nov; 69():908-19. PubMed ID: 24125851
[TBL] [Abstract][Full Text] [Related]
10. Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models.
Azevedo CM; Afonso CM; Soares JX; Reis S; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Gales L; Pinto MM
Eur J Med Chem; 2013 Nov; 69():798-816. PubMed ID: 24113365
[TBL] [Abstract][Full Text] [Related]
11. The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Du Y; Song L; Zhang L; Ling H; Zhang Y; Chen H; Qi H; Shi X; Li Q
Eur J Med Chem; 2017 Aug; 136():457-467. PubMed ID: 28525844
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways.
Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN
Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.
Jiao J; Fang H; Wang X; Guan P; Yuan Y; Xu W
Eur J Med Chem; 2009 Nov; 44(11):4470-6. PubMed ID: 19608304
[TBL] [Abstract][Full Text] [Related]
14. N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: a novel class of antitumor agents targeting the colchicine site on tubulin.
Wang XF; Wang SB; Ohkoshi E; Wang LT; Hamel E; Qian K; Morris-Natschke SL; Lee KH; Xie L
Eur J Med Chem; 2013 Sep; 67():196-207. PubMed ID: 23867604
[TBL] [Abstract][Full Text] [Related]
15. Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.
Ozkan T; Hekmatshoar Y; Ertan-Bolelli T; Hidayat AN; Beksac M; Aki-Yalcin E; Yalcin I; Sunguroglu A
Anticancer Agents Med Chem; 2018; 18(11):1521-1530. PubMed ID: 29298654
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.
Xie Z; Cheng D; Luo L; Shen G; Pan S; Pan Y; Chen B; Wang X; Liu Z; Zhang Y; Ye F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):905-919. PubMed ID: 29734851
[TBL] [Abstract][Full Text] [Related]
17. Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing.
Muktapuram PR; Gara RK; Sharma K; Rohit C; Srinivas K; Mishra DP; Bathula SR
Eur J Med Chem; 2012 Oct; 56():400-8. PubMed ID: 22926227
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents.
Zhang J; Xiong H; Yang F; He J; Chen T; Fu D; Zheng P; Tang Q
Bioorg Med Chem Lett; 2021 Feb; 33():127740. PubMed ID: 33316412
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antiproliferative activity evaluation of m-(4-morpholinyl-1,3,5-triazin-2-yl)benzamides in vitro.
Wang XM; Xu J; Xin MH; Lu SM; Zhang SQ
Bioorg Med Chem Lett; 2015 Apr; 25(8):1730-1735. PubMed ID: 25765909
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
